portal vein
n. [解剖] 门静脉
2025-11-24 18:14 浏览次数 11
n. [解剖] 门静脉
angiography of portal vein门静脉间接造影
partial portal-vein ligation门静脉部分结扎
portal stem vein tumor thrombus门静脉主干癌栓
portal vein tumor thrombus门静脉癌栓
portal vein flow门静脉血流
Portal vein arterialization门静脉动脉化
portal l vein门静脉
portal vein injection门静脉注射
Portal stem vein门静脉主干
objective: to study the effects of immunological tolerance induced by administration of allogeneic splenocytes through portal vein in rats in combination with daclizumab.
目的:观察异基因脾细胞经门静脉途径输注诱导受体免疫耐受的效果,以及联合使用塞尼哌后的效果。
methods the ultrasonographic data of 12 cases of portal vein thrombosis after splenectomy were analyzed retrospectively.
方法回顾分析了12例患者,脾切除术后门静脉系统血栓形成患者的超声检查资料。
objective to evaluate the diagnostic value of ultrasound in portal vein thrombosis after splenectomy.
目的评价超声检查对脾切除术后门脉系统血栓形成的诊断价值。
results among the 12 cases of portal vein thrombosis after splenectomy, the detective rate by ultrasound was 100%.
结果12例脾切除术后门静脉系统血栓形成患者超声检查诊断符合率达100%。
objective to research the anticoagulants in protecting the portal vein obstruction after splenectomy due to the portal hypertension of hepatic cirrhosis.
目的:探讨肝硬化、门脉高压癥行脾切除术后早期应用抗凝药物对预防门静脉血栓的意义。
objective to discuss the safety limit of portal vein embolization, to evaluate the feasibility and efficacy of bletilla microsphere used as an embolic agent for portal vein.
目的探讨门静脉栓塞的安全范围及白芨微球作为门静脉栓塞剂的可行性与有效性。
objective to investigate the long-term effects of portal vein hemodynamic changes on liver function after portal vein arterialization(pva) in rats.
目的:探讨大鼠门静脉完全动脉化(pva )后门静脉血液动力学的变化对肝脏功能的远期影响。
purpose to study and evaluate the technique feasibility and clinical efficacy of percutaneous treatment for portal vein thrombosis(pvt).
目的:研究和评价经皮治疗门静脉血栓技术的可行性和临床效果。
selective puncture to embolize the left-middle portal vein with the different concentration, dosage and the injection speed of nbca.
穿刺左中支门静脉,以不同浓度、剂量和推注速度的nbca栓塞该血管。
objective:to introduce a new therapy combining percutaneous laser and photosensitizer in treatment of portal vein tumor thrombus(pvtt), and evaluate the efficacy and validity of the method.
目的:介绍肝癌门静脉癌栓激光联合光敏剂治疗的方法,并探讨这一治疗方法的安全性和有效性。
method:intrahepatic portal vein flow was measured by using color doppler ultrasonography in212patients who underwent tipss.
方法:采用彩色多普勒超声测量212例tipss术后患者的肝内门静脉血流。
objective to explore the value of color doppler image (cdi) in monitoring of portal vein (pv) complications following orthotopic liver transplantation (olt).
目的探讨彩色多普勒超声(cdi)监测肝移植术后门静脉并发癥的应用价值。
if the patient is very reliable and has no other contra-indications for anticoagulation, then it could be the best choice for that particular patient if they have isolated portal vein thrombosis.
如果病人很可靠,并且没有其他抗凝治疗禁忌癥,如果已分离出特定的门静脉血栓形成病人,那它就可以是最好的选择。
postoperative death occurred in 1 patient in each group. vascular complications included anastomotic strictures: 2 portal vein (pv), 1 hepatic artery (ha), and 1 rhv anastomotic strictures; all in gi.
各组术后均有1例死亡。吻合口狭窄血管并发癥均在组1发生:2例发生在门静脉,1例在肝动脉,1例在右肝静脉。
result: (1) the density-time curves about the regions of interest (rot)were showed to describe the enhancement characteristics of ctsp on the hepaticparenchyma, portal vein and aorta vividly.
结果:(1)展示了肝实质、门静脉及主动脉时间-密度曲线,直观描述了其强化特性;
overall mean recipient portal vein flow (pvf) was much higher than the left pvf in the donors.
总体平均受体门静脉血流量较供体门脉左支血流量要高得多。
hie hepatic artery played a important role in the blood supply of the cavernous hemangioma of the liver, but the portal vein is lesser.
肝脏海绵状血管瘤存在肝动脉及门静脉双重血液供应,但肝动脉在肿瘤供血方面起着决定性作用;
objective to study and evaluate the technique feasibility and clinical efficacy of percutaneous treatment for portal vein thrombosis(pvt).
目的研究和评价经皮治疗门静脉及其属支血栓的技术可行性和临床效果。
objective to evaluate the value of color doppler ultrasound in diagnosing complications after orthotopic liver transplantation(olt) in patients with portal vein thrombosis(pvt).
目的探讨彩色多普勒超声对合并门静脉栓塞者进行肝移植术后并发癥的诊断价值。
hepatology digest: at a session you are moderating at this meeting, there is a question: portal vein thrombosis: anticoagulation? yes or no? what is your opinion about that?
《国际肝病》: 本次会议在你主持的一节,有一个问题:门静脉血栓形成:抗凝治疗?是或否?您对此有什么看法?